Literature DB >> 21257612

Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.

E Dale Abel1, Torsten Doenst.   

Abstract

Cardiac hypertrophy is a stereotypic response of the heart to increased workload. The nature of the workload increase may vary depending on the stimulus (repetitive, chronic, pressure, or volume overload). If the heart fully adapts to the new loading condition, the hypertrophic response is considered physiological. If the hypertrophic response is associated with the ultimate development of contractile dysfunction and heart failure, the response is considered pathological. Although divergent signalling mechanisms may lead to these distinct patterns of hypertrophy, there is some overlap. Given the close relationship between workload and energy demand, any form of cardiac hypertrophy will impact the energy generation by mitochondria, which are the key organelles for cellular ATP production. Significant changes in the expression of nuclear and mitochondrially encoded transcripts that impact mitochondrial function as well as altered mitochondrial proteome composition and mitochondrial energetics have been described in various forms of cardiac hypertrophy. Here, we review mitochondrial alterations in pathological and physiological hypertrophy. We suggest that mitochondrial adaptations to pathological and physiological hypertrophy are distinct, and we shall review potential mechanisms that might account for these differences.

Entities:  

Mesh:

Year:  2011        PMID: 21257612      PMCID: PMC3115280          DOI: 10.1093/cvr/cvr015

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  108 in total

1.  Nitric oxide and AMPK cooperatively regulate PGC-1 in skeletal muscle cells.

Authors:  Vitor A Lira; Dana L Brown; Ana K Lira; Andreas N Kavazis; Quinlyn A Soltow; Elizabeth H Zeanah; David S Criswell
Journal:  J Physiol       Date:  2010-07-19       Impact factor: 5.182

Review 2.  Aortic stenosis: from pressure overload to heart failure.

Authors:  Blase A Carabello
Journal:  Heart Fail Clin       Date:  2006-10       Impact factor: 3.179

3.  Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1.

Authors:  Tao Hang; Zhaoqi Huang; Shisen Jiang; Jianbin Gong; Chunhui Wang; Dujiang Xie; Hailing Ren
Journal:  Ann Clin Lab Sci       Date:  2006       Impact factor: 1.256

4.  Exacerbation of chronic renovascular hypertension and acute renal failure in heme oxygenase-1-deficient mice.

Authors:  P Wiesel; A P Patel; I M Carvajal; Z Y Wang; A Pellacani; K Maemura; N DiFonzo; H G Rennke; M D Layne; S F Yet; M E Lee; M A Perrella
Journal:  Circ Res       Date:  2001-05-25       Impact factor: 17.367

5.  Reactive oxygen species generated by the mitochondrial respiratory chain affect the complex III activity via cardiolipin peroxidation in beef-heart submitochondrial particles.

Authors:  G Paradies; G Petrosillo; M Pistolese; F M Ruggiero
Journal:  Mitochondrion       Date:  2001-08       Impact factor: 4.160

6.  NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart.

Authors:  Junya Kuroda; Tetsuro Ago; Shouji Matsushima; Peiyong Zhai; Michael D Schneider; Junichi Sadoshima
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

7.  Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure.

Authors:  Heiko Bugger; Michael Schwarzer; Dong Chen; Andrea Schrepper; Paulo A Amorim; Maria Schoepe; T Dung Nguyen; Friedrich W Mohr; Oleh Khalimonchuk; Bart C Weimer; Torsten Doenst
Journal:  Cardiovasc Res       Date:  2009-10-19       Impact factor: 10.787

Review 8.  Diabetic cardiomyopathy revisited.

Authors:  Sihem Boudina; E Dale Abel
Journal:  Circulation       Date:  2007-06-26       Impact factor: 29.690

Review 9.  Animal models of human cardiovascular disease, heart failure and hypertrophy.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

10.  Interaction of myocardial insulin receptor and IGF receptor signaling in exercise-induced cardiac hypertrophy.

Authors:  Hiroyuki Ikeda; Ichiro Shiojima; Yukako Ozasa; Masashi Yoshida; Martin Holzenberger; C Ronald Kahn; Kenneth Walsh; Takashi Igarashi; E Dale Abel; Issei Komuro
Journal:  J Mol Cell Cardiol       Date:  2009-09-08       Impact factor: 5.000

View more
  123 in total

1.  Mitochondrial Akt-regulated mitochondrial apoptosis signaling in cardiac muscle cells.

Authors:  Ching-Chieh Su; Jia-Ying Yang; Hsin-Ban Leu; Yumay Chen; Ping H Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-11       Impact factor: 4.733

Review 2.  Metabolic stress in the myocardium: adaptations of gene expression.

Authors:  Peter A Crawford; Jean E Schaffer
Journal:  J Mol Cell Cardiol       Date:  2012-06-21       Impact factor: 5.000

3.  Downregulation of IDH2 exacerbates H2O2-mediated cell death and hypertrophy.

Authors:  Hyeong Jun Ku; Jeen-Woo Park
Journal:  Redox Rep       Date:  2016-02-15       Impact factor: 4.412

Review 4.  Proteostasis and REDOX state in the heart.

Authors:  Elisabeth S Christians; Ivor J Benjamin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-14       Impact factor: 4.733

5.  Pediatric and adult dilated cardiomyopathy represent distinct pathological entities.

Authors:  Meghna D Patel; Jayaram Mohan; Caralin Schneider; Geetika Bajpai; Enkhsaikhan Purevjav; Charles E Canter; Jeffrey Towbin; Andrea Bredemeyer; Kory J Lavine
Journal:  JCI Insight       Date:  2017-07-20

6.  GLUT1 deficiency in cardiomyocytes does not accelerate the transition from compensated hypertrophy to heart failure.

Authors:  Renata O Pereira; Adam R Wende; Curtis Olsen; Jamie Soto; Tenley Rawlings; Yi Zhu; Christian Riehle; E Dale Abel
Journal:  J Mol Cell Cardiol       Date:  2014-02-25       Impact factor: 5.000

Review 7.  Lipid metabolites and their differential pro-arrhythmic profiles: of importance in the development of a new anti-arrhythmic pharmacology.

Authors:  Yangzhen Shao; Bjorn Redfors; David Benoist; Sigfus Gizurarson; Elmir Omerovic
Journal:  Mol Cell Biochem       Date:  2014-04-27       Impact factor: 3.396

8.  Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo.

Authors:  Roberto Mota; Traci L Parry; Cecelia C Yates; Zhaoyan Qiang; Samuel C Eaton; Jean Marie Mwiza; Deepthi Tulasi; Jonathan C Schisler; Cam Patterson; Tania Zaglia; Marco Sandri; Monte S Willis
Journal:  Am J Pathol       Date:  2018-05-23       Impact factor: 4.307

9.  Pyruvate modifies metabolic flux and nutrient sensing during extracorporeal membrane oxygenation in an immature swine model.

Authors:  Dolena R Ledee; Masaki Kajimoto; Colleen M O'Kelly Priddy; Aaron K Olson; Nancy Isern; Isabelle Robillard-Frayne; Christine Des Rosiers; Michael A Portman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

Review 10.  Molecular basis of physiological heart growth: fundamental concepts and new players.

Authors:  Marjorie Maillet; Jop H van Berlo; Jeffery D Molkentin
Journal:  Nat Rev Mol Cell Biol       Date:  2013-01       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.